Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Labcorp Holdings ( (LH) ) has issued an update.
On January 14, 2026, Labcorp Holdings Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.72 per share of common stock, payable on March 12, 2026, to shareholders of record as of the close of business on February 27, 2026. The move signals continued commitment to returning capital to shareholders and reflects management’s confidence in the company’s cash generation and financial stability, which may bolster Labcorp’s appeal to income-focused investors in the healthcare and diagnostics sector.
The most recent analyst rating on (LH) stock is a Buy with a $325.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings demonstrates strong financial performance and strategic growth initiatives, particularly in the Diagnostics and Central Laboratories segments. While technical indicators suggest a bearish trend, the company’s focus on high-growth areas and technological innovation provides a positive outlook. Valuation metrics indicate the stock is fairly valued, with potential for growth if earnings continue to improve. Recent corporate events further support the company’s strategic direction.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. (NYSE: LH) is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities that support doctors, hospitals, pharmaceutical companies, researchers and patients. With nearly 70,000 employees serving clients in about 100 countries, the company conducts more than 700 million tests annually and supported 75% of the new drugs and therapeutic products approved by the FDA in 2024, underscoring its central role in global healthcare and life sciences.
Average Trading Volume: 826,554
Technical Sentiment Signal: Buy
Current Market Cap: $20.76B
Find detailed analytics on LH stock on TipRanks’ Stock Analysis page.